Catalog Number 324910 |
Device Problem
Volume Accuracy Problem (1675)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 05/02/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Date of event: unknown.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Event Description
|
It was reported that bd veo¿ insulin syringes with bd ultra-fine¿ needles experienced 100 cases of scale marking issues.The following information was provided by the initial reporter: the very first scale mark (the zero point) is way lower than it should be, which makes me inject more insulin than measured.
|
|
Manufacturer Narrative
|
H.6.A complaint lot history check was performed on lot # 1144160 for scale misaligned.This is the 1st related complaint for scale misaligned on lot # 1144160.Investigation summary: customer returned (3) 0.3ml syringes.Each of the syringes were measured using a gauge pertaining to the positioning of the graduation marks.While the graduation marks on all of the syringes were found to have placed lower along the barrel of the syringe than average, all of the graduation marks were still within acceptable values.A review of the device history record was completed for batch # 1144160 all inspections were performed per the applicable operations qc specifications.There was one (1) notification [(b)(4)] noted that did not pertain to the complaint.Based on the samples received, embecta was unable to confirm the customer¿s indicated failure of the scale markings being misaligned.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.Root cause cannot be determined at this time as the issue is unconfirmed.Based on the investigation, no capa/sa is required at this time.
|
|
Event Description
|
It was reported that bd veo¿ insulin syringes with bd ultra-fine¿ needles experienced 100 cases of scale marking issues.The following information was provided by the initial reporter: the very first scale mark (the zero point) is way lower than it should be, which makes me inject more insulin than measured.
|
|
Search Alerts/Recalls
|